时间毒性和大脑的共享决策
David B Frumberg1, Paige T Church2, Nathan Rosenberg3
1Yale School of Medicine, Department of Orthopaedics & Rehabilitation, New Haven, CT, USA.
Developmental medicine and child neurology
|December 12, 2025
概括
时间毒性或与时间相关的负担在残疾人的共同医疗决策中经常被忽视. 这项研究建议将时间毒性纳入医疗保健结果措施,以获得更好的以患者为中心的护理.
科学领域:
- 医疗保健研究的研究.
- 关于残疾人的研究.
- 患者为中心的结果.
背景情况:
- 在医疗保健中,临床医生和家庭之间的共同决策是常见的.
- 与时间相关的负担,或"时间毒性",在瘤学中越来越被认可,但在其他领域经常被忽视,比如脑研究.
- 未解决的时间负担对残疾人的影响在很大程度上是未知的.
研究的目的:
- 引入并倡导将"时间毒性"作为残疾人医疗保健中的关键结果措施.
- 在瘤学领域的现有研究基础上,为更广泛的患者群体适应时间毒性概念.
- 突出与时间相关的负担的潜在深远影响,这些负担目前在残疾研究中没有被考虑.
主要方法:
- 这项研究是概念性的,基于瘤学的现有文献.
- 它建议将"时间毒性"框架应用于经常与医疗保健系统互动的残疾人.
- 需要定性或定量研究方法来正式评估这个人群中的时间毒性.
主要成果:
- 目前,与时间相关的负担并没有被系统地衡量为残疾人医疗保健的结果,特别是在诸如脑等疾病中.
- 缺乏测量表明,在了解医疗保健干预措施对患者生活的全部影响方面存在潜在的差距.
- "时间毒性"的概念提供了一个新的镜头来评估患者的体验和负担.
结论:
- 时间毒性是残疾人医疗体验的一个重要,但尚未研究的因素.
- 将时间毒性纳入结果测量可以导致更全面和以患者为中心的护理计划.
- 需要进一步的研究来量化和解决残疾人医疗保健中与时间相关的负担.
相关概念视频
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
174
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
174
01:21Factors Affecting Drug Response: Overview
2.8K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.8K
01:23Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
602
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
602
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
194
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
194